Skip to main content
. 2012 Mar 7;2012:183983. doi: 10.5402/2012/183983

Figure 3.

Figure 3

Use of topical immunosuppressors in baseline and after 12 months of treatment. Points were assigned according to dose, frequency of use, and relative potency of the steroid used. Blue: Active Group. Red: Control Group. *P ≤ 0.05;  n = 60; Mann-Whitney U test, Wilcoxon test.